Transcatheter Aortic Valve Replacement for Heart Valve Diseases
Transpacific TAVR Registry
Recruiting
Observational Study
Heart Valve Diseases
Aortic Valve Insufficiency
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 19 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 10,000 (estimated)
- Sponsor
- Duk-Woo Park, MD · Other
Who this trial is looking for
This trial is looking for patients who are having a Transcatheter aortic valve replacement (TAVR). To participate, you need to provide informed consent.
Are You a Good Fit for This Trial?
You may be able to join if
- I am undergoing TAVR
- I provide informed consent
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
This registry evaluates the long-term outcome of Transcatheter aortic valve replacement (TAVR) in real-world clinical practice.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* All patients undergoing TAVR
* Informed consent
Contacts